100322-43-8

Basic information

• Product Name: 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-benzo[a]quinolizine-2-one
• CAS NO: 100322-43-8
• Molecular Weight: 315.412
• Mol File: 100322-43-8.mol

Chemical Properties

• Melting Point: 155-158°C
• CAS DataBase Reference: 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-benzo[a]quinolizine-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-benzo[a]quinolizine-2-one(100322-43-8)
• EPA Substance Registry System: 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-benzo[a]quinolizine-2-one(100322-43-8)

Safety Data

• Hazardous Substances Data: 100322-43-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-benzo[a]quinolizine-2-one is used as a pharmaceutical compound for its potential therapeutic effects. The compound's unique structure may allow it to interact with specific biological targets, making it a candidate for the development of new drugs.
Used in Chemical Research:
In the field of chemical research, 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-benzo[a]quinolizine-2-one can be used as a starting material or intermediate for the synthesis of other complex organic molecules. Its unique structural features may enable the development of novel chemical entities with various applications.
Used in Material Science:
The compound may also find applications in material science, where its specific properties could be utilized in the development of new materials with tailored characteristics. For example, its structural features might contribute to the creation of materials with specific optical, electronic, or mechanical properties.

Upstream product

• 718635-93-9 tetrabenazine 
• 110-12-3 5-Methyl-2-hexanone 
• 513-38-2 Isobutyl iodide 

Relevant articles and documents

Structural requirement of C11b chirality of tetrabenazine analogs as VMAT2 imaging ligands: synthesis and in vivo evaluation

We studied on the structural requirement of C11b chirality of tetrabenazine (TBZ) analogs as vesicular monoamine transporter 2 (VMAT2) ligands. TBZ analogs (2, 6a, 6b) and 18F-radiolabeled [18F]6a and [18F]6b with eliminat

Synthesis of 3H-labeled Tetrabenazine (TBZ)

Tetrabenazine (TBZ) (1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2- methylpropyl)-2H-benzo[a]quinolin-2-one), a vesicular monamine transporter 2 inhibitor, was prepared as a tritium-labeled compound with high specific activity and radiochemical purity. Catalytic hydrogenation of a precursor with the terminal double bond was used to introduce the tritium. This method provides tritium-labeled TBZ with high specific activity and radiochemical purity, which allow the further investigation of a TBZ in the neurological field.

A novel reaction of cyanogen iodide with cyclic tertiary amines

It has been shown that cyanogen iodide reacts with the tertiary amine ring of marcfortine A (1) to give cyano (4) and iodocyano (3) substituted products. We have now extended this reaction to various cyclic tertiary amines.

Expanding insight into asymmetric palladium-catalyzed allylic alkylation of N-heterocyclic molecules and cyclic ketones

Eeny, meeny, miny.?? enaminones! Lactams and imides have been shown to consistently provide enantioselectivities substantially higher than other substrate classes previously investigated in the palladium-catalyzed asymmetric decarboxylative allylic alkylation. Several new substrates have been designed to probe the contributions of electronic, steric, and stereoelectronic factors that distinguish the lactam/imide series as superior alkylation substrates (see scheme). These studies culminated in marked improvements on carbocyclic allylic alkylation substrates. Copyright